Finch Therapeutics, Inc.
Somerville, MA · Founded 2014 · CIK 0001661704 · Biotech · Defunct
Microbiome-derived therapeutic candidates engineered from human gut bacteria
finchtherapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $4.5M
- 2 Form D · Jan 2017
- 117 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 0 granted · 10 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $800,000 | |
| Private capital raised | Form D · SEC | $3,734,177 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2649 | Integrated Micro-Chromatography Systems, Inc. | — | $150K |
| 2650 | SIDERO BIOSCIENCE, LLC | — | $145K |
| 2651 | ORION THERAPEUTICS INC. | — | $145K |
| 2652 | Finch Therapeutics, Inc. | — | $4.5M |
| 2653 | TARTAN LLC | — | $130K |
| 2654 | NEUIMMUNE, INC. | — | $125K |
| 2655 | RESTORE THERAPEUTICS LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Eric AlmPromoter
- James BurgessDirector · Promoter
- Zain KassamPromoter
- Andrew NohDirector · Executive Officer · Promoter
- William PerkinsExecutive Officer
- Mark SmithDirector · Executive Officer · Promoter
Patents
- Treatment Of Liver Disease By Modulation Of The Microbiomeapplication
- Compositions And Methods For Maintaining And Restoring A Healthy Gut Barrierapplication
- Compositions And Methods For Decolonizing Antibotic-resistant Bacteria In The Gutapplication
- Treatment Of Liver Disease By Modulation Of The Microbiomeapplication
- Pharmaceutical Compositions And Methods For Delivering Microbial Compositionsapplication
- Treatment Of Liver Disease By Modulation Of The Microbiomeapplication
- Compositions And Methods For Maintaining And Restoring A Healthy Gut Barrierapplication
- Compositions And Methods For Decolonizing Antibiotic-resistant Bacteria In The Gutapplication
- Delivery Of Microbial Compositionsapplication
- Articles And Methods For Delivering Microbial Compositionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.